BVF PARTNERS L P/IL Insider Trading $ARQL ARQULE INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BVF PARTNERS L P/IL.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).

Over the past year BVF PARTNERS L P/IL has been an insider in 11 companies. The total value of shares held by BVF PARTNERS L P/IL in these companies amounts to $226,487,611.

BVF PARTNERS L P/IL 10% Owner
ALPINE IMMUNE SCIENCES, INC.
10% Owner
ARQULE INC
10% Owner
Calithera Biosciences, Inc.
Capstone Therapeutics Corp.
ChemoCentryx, Inc.
10% Owner
CONCERT PHARMACEUTICALS, INC.
Director, 10% Owner
CTI BIOPHARMA CORP
CYTOKINETICS INC
Eledon Pharmaceuticals, Inc.
FIVE PRIME THERAPEUTICS, INC.
10% Owner
GLYCOMIMETICS INC
IDEAYA Biosciences, Inc.
10% Owner
IMMUNE DESIGN CORP.
10% Owner
INFINITY PHARMACEUTICALS, INC.
Director
Kymera Therapeutics, Inc.
10% Owner
Merus N.V.
Director
Olema Pharmaceuticals, Inc.
10% Owner
PIERIS PHARMACEUTICALS, INC.
10% Owner
Principia Biopharma Inc.
Director
Rain Therapeutics Inc.
10% Owner
Syndax Pharmaceuticals Inc
10% Owner
Xenon Pharmaceuticals Inc.
Director, 10% Owner
XOMA Corp
$ 226487611 The total value of shares held by BVF PARTNERS L P/IL
Insider Rank

BVF PARTNERS L P/IL ranks 207 out of 350,000 insiders. Go to Insider Ranking to see more.

BVF PARTNERS L P/IL in ARQULE INC

Trading Symbol: ARQL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 4,682,669 shares
Current Value: $6,415,257
Latest Transaction: Jun 01 2018
$ARQL Market Capitalization: $96.01M
$ARQL Previous Close: $1.37

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL

Last 3 Months Overview:
Buy: 0x
Sell: 9x
Shares Bought: 0
Shares Sold: 5,567,893
Share Difference: -5,567,893
Value Difference: +$18,768,540

Latest Insider Trading Transactions of BVF PARTNERS L P/IL in ARQULE INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 01 2018ARQLARQULE INCBVF PARTNERS L P/IL10% OwnerSellS5.00175,813879,083771,305947.1 K to 771.3 K (-18.56 %)
Jun 01 2018ARQLARQULE INCBVF PARTNERS L P/IL10% OwnerSellS5.00312,2661,561,3613,186,0443.5 M to 3.2 M (-8.93 %)
Jun 01 2018ARQLARQULE INCBVF PARTNERS L P/IL10% OwnerSellS5.00547,8602,739,3554,682,6695.2 M to 4.7 M (-10.47 %)
Apr 20 2018ARQLARQULE INCBVF PARTNERS L P/IL10% OwnerSellS3.10217,256673,494947,1181.2 M to 947.1 K (-18.66 %)
Apr 20 2018ARQLARQULE INCBVF PARTNERS L P/IL10% OwnerSellS3.10808,4492,506,1923,498,3104.3 M to 3.5 M (-18.77 %)
Apr 20 2018ARQLARQULE INCBVF PARTNERS L P/IL10% OwnerSellS3.101,204,6683,734,4715,230,5296.4 M to 5.2 M (-18.72 %)
Apr 06 2018ARQLARQULE INCBVF PARTNERS L P/IL10% OwnerSellS2.90214,336621,5741,164,3741.4 M to 1.2 M (-15.55 %)
Apr 06 2018ARQLARQULE INCBVF PARTNERS L P/IL10% OwnerSellS2.90817,6112,371,0724,306,7595.1 M to 4.3 M (-15.96 %)
Apr 06 2018ARQLARQULE INCBVF PARTNERS L P/IL10% OwnerSellS2.901,269,6343,681,9396,435,1977.7 M to 6.4 M (-16.48 %)

Page:   1